BETH ISRAEL DEACONESS MEDICAL CENTER

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
1896-01-01
Employees
-
Market Cap
-
Website
https://www.bidmc.org/

Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease

First Posted Date
2011-05-06
Last Posted Date
2013-08-19
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
106
Registration Number
NCT01349504
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Effectiveness of Open and Robotic Prostatectomy

Completed
Conditions
Interventions
First Posted Date
2011-03-29
Last Posted Date
2024-11-06
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
677
Registration Number
NCT01325506
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Emory Healthcare, Atlanta, Georgia, United States

๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins, Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Michigan, Ann Arbor, Michigan, United States

and more 6 locations

Coenzyme Q10 in Post-Cardiac Arrest Cerebral Resuscitation

First Posted Date
2011-03-21
Last Posted Date
2017-07-31
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
10
Registration Number
NCT01319110
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

The VMVN Study: Virological Monitoring in Viet Nam

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2011-03-17
Last Posted Date
2018-08-03
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
650
Registration Number
NCT01317498
Locations
๐Ÿ‡ป๐Ÿ‡ณ

Bach Mai Hospital, Hanoi, Vietnam

Electronic Medical Record Reminders and Panel Management to Improve Primary Care of Elderly Patients

First Posted Date
2011-03-11
Last Posted Date
2017-03-14
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
54
Registration Number
NCT01313169
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer

Phase 2
Completed
Conditions
Interventions
First Posted Date
2011-02-18
Last Posted Date
2020-02-05
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
20
Registration Number
NCT01299038
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

๐Ÿ‡บ๐Ÿ‡ธ

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Effect of Supplemental Oxygen on Maximal Oxygen Consumption in Patients With Chronic Obstructive Pulmonary Disease

First Posted Date
2011-02-11
Last Posted Date
2017-03-16
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
20
Registration Number
NCT01294033
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma

Completed
Conditions
Interventions
First Posted Date
2011-02-03
Last Posted Date
2023-06-15
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
153
Registration Number
NCT01288963
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

In Vivo Leptin Signaling in Humans After Acute Leptin Administration

Phase 1
Completed
Conditions
Interventions
First Posted Date
2011-01-12
Last Posted Date
2017-10-17
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
12
Registration Number
NCT01275053
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer

First Posted Date
2010-12-01
Last Posted Date
2014-02-04
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
28
Registration Number
NCT01250717
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath